![PRD_001158 PRD_001158](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001158.svg) | PRD_001158 | Name: | Teicoplanin pseudoaglycone | Formula: | C78 H79 Cl2 N9 O32 | Definition date: | 2014-09-03 | Last modified: | 2014-09-03 |
|
![PRD_001169 PRD_001169](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001169.svg) | PRD_001169 | Name: | Teicoplanin pseudoaglycone | Formula: | C88 H97 Cl2 N9 O33 | Definition date: | 2014-09-03 | Last modified: | 2014-09-03 |
|
![PRD_001230 PRD_001230](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/2YS.svg) | PRD_001230 | Name: | D-valyl-N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-L-leucinamide | Formula: | C18 H37 Cl N4 O3 | Definition date: | 2014-09-03 | Last modified: | 2017-09-14 |
|
![PRD_001231 PRD_001231](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/2YT.svg) | PRD_001231 | Name: | L-phenylalanyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide | Formula: | C25 H35 Cl N6 O3 | Definition date: | 2014-09-03 | Last modified: | 2017-09-14 |
|
![PRD_001244 PRD_001244](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/3E5.svg) | PRD_001244 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(2S,3S)-1-[(2,4-dimethylphenyl)amino]-2-hydroxy-5-methyl-1-oxohexan-3-yl}-L-leucinamide | Formula: | C35 H52 N4 O6 | Definition date: | 2014-08-13 | Last modified: | 2017-09-14 |
|
![PRD_002101 PRD_002101](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002101.svg) | PRD_002101 | Name: | N-[(6R,9S,10R,13S,15aR,22S,24aR)-22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-18-(morpholin-4-ylmethyl)-5,8,12,15,21,24-hexaoxo-13-phenyl-1,2,3,5,6,7,8,9,10,13,14,15,15a,16,19,21,22,23,24,24a-icosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxypyridine-2-carboxamide | Formula: | C50 H63 N9 O10 | Definition date: | 2014-07-30 | Last modified: | 2014-07-30 |
|
![PRD_001171 PRD_001171](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001171.svg) | PRD_001171 | Name: | Serine protease inhibitor BEZ-NLE-LYS-ARG-M9P | Formula: | C32 H57 F3 N11 O5 | Definition date: | 2014-07-08 | Last modified: | 2014-07-08 |
|
![PRD_002092 PRD_002092](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002092.svg) | PRD_002092 | Name: | L-alanyl-3,5-dibromo-L-tyrosyl-L-alanine | Formula: | C15 H19 Br2 N3 O5 | Definition date: | 2014-07-08 | Last modified: | 2014-07-08 |
|
![PRD_001161 PRD_001161](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/EC6.svg) | PRD_001161 | Name: | N-hexanoyl-L-valyl-N~1~-[(4S,5S,6R)-5-hydroxy-2,6-dimethyloctan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C28 H54 N4 O5 | Description: | Originated from (S)-N1-((S,Z)-2,6-dimethyl-5-oxooct-6-en-4-yl)-2-((S)-2-hexanamido-3-methylbutanamido)-N5,N5-dimethylpentanediamide that reacts with N-terminal Thr of the protein, opening double bonds of the original compound and making two covalent linkages with the amino group and side chain hydroxyl of the Thr. The PRD represents the bound form. | Definition date: | 2014-07-02 | Last modified: | 2017-09-14 |
|
![PRD_001078 PRD_001078](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001078.svg) | PRD_001078 | Name: | Peptide inhibitor MPT-DPP-DAR-G-DPN-NH2 | Formula: | C23 H38 N9 O5 S | Definition date: | 2014-06-25 | Last modified: | 2014-06-25 |
|
![PRD_001163 PRD_001163](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/29D.svg) | PRD_001163 | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | Formula: | C34 H40 N10 O15 | Definition date: | 2014-06-18 | Last modified: | 2017-09-14 |
|
![PRD_001164 PRD_001164](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/29C.svg) | PRD_001164 | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | Formula: | C29 H33 N9 O12 | Definition date: | 2014-06-18 | Last modified: | 2017-09-14 |
|
![PRD_001165 PRD_001165](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/28Z.svg) | PRD_001165 | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-glutamic acid | Formula: | C24 H26 N8 O9 | Definition date: | 2014-06-18 | Last modified: | 2017-09-14 |
|
![PRD_001237 PRD_001237](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001237.svg) | PRD_001237 | Name: | Boc-Ala-Ala-Ala-Al-CHO | Formula: | C14 H27 N3 O5 | Definition date: | 2014-06-18 | Last modified: | 2023-11-03 |
|
![PRD_001238 PRD_001238](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001238.svg) | PRD_001238 | Name: | PEPSTATIN ANALOGUE ISOVALERYL-VAL-VAL-STA-O-ET | Formula: | C25 H47 N3 O6 | Definition date: | 2014-06-04 | Last modified: | 2017-05-04 |
|
![PRD_001162 PRD_001162](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001162.svg) | PRD_001162 | Name: | Salinamide A | Formula: | C51 H69 N7 O15 | Description: | bicyclic depsipeptide salinamide A is a potent anti-inflammatory agent found in the marine bacterium Streptomyces sp. CNB-091. The suggested biosynthesis pathway indicates the peptide core of 1 is probably derived from the hexapeptide Thr-D-Ile-Hpg-MePhe-D-aThr-Ser (Tetrahedron Letters 39 (1998) 3915-3918). | Definition date: | 2014-05-21 | Last modified: | 2014-05-21 |
|
![PRD_001215 PRD_001215](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001215.svg) | PRD_001215 | Name: | Macrocyclic Inhibitor (3R,6S,9S,12E,16S)-9-(3-AMINO-3-OXO-PROPYL)-3-[(4-BENZOYLPHENYL)METHYL]-6-(CYCLOHEXYLMETHYL)-2,5,8,11,14-PENTAOXO-1,4,7,10,15-PENTAZACYCLOICOS-12-ENE-16-CARBOXAMIDE | Formula: | C40 H48 N7 O9 | Definition date: | 2014-05-21 | Last modified: | 2023-11-03 |
|
![PRD_001181 PRD_001181](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001181.svg) | PRD_001181 | Name: | GE23077 | Formula: | C31 H49 N9 O16 | Definition date: | 2014-05-07 | Last modified: | 2014-05-07 |
|
![PRD_001216 PRD_001216](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001216.svg) | PRD_001216 | Name: | Somatostatin-14 | Formula: | C76 H108 N18 O19 S2 | Definition date: | 2014-05-07 | Last modified: | 2014-05-07 |
|
![PRD_001059 PRD_001059](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001059.svg) | PRD_001059 | Name: | Trypsin inhibitor 1 | Formula: | C71 H104 N19 O17 S2 | Definition date: | 2014-04-30 | Last modified: | 2014-04-30 |
|
![PRD_001229 PRD_001229](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001229.svg) | PRD_001229 | Name: | anti-CmABCB1 peptide | Formula: | C100 H139 N24 O26 S | Definition date: | 2014-04-30 | Last modified: | 2014-04-30 |
|
![PRD_001097 PRD_001097](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001097.svg) | PRD_001097 | Name: | Trypsin inhibitor 1 | Formula: | C67 H106 N18 O18 S2 | Definition date: | 2014-04-23 | Last modified: | 2014-04-23 |
|
![PRD_001217 PRD_001217](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/2OY.svg) | PRD_001217 | Name: | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide (Bound Form) | Formula: | C14 H23 Cl N2 O3 S | Definition date: | 2014-04-23 | Last modified: | 2017-09-14 |
|
![PRD_000973 PRD_000973](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000973.svg) | PRD_000973 | Name: | Trypsin inhibitor 1 | Formula: | C71 H103 N18 O18 S2 | Definition date: | 2014-04-09 | Last modified: | 2014-04-09 |
|
![PRD_001220 PRD_001220](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001220.svg) | PRD_001220 | Name: | meta-guanidinomethyl-phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | Formula: | C35 H57 N15 O4 | Definition date: | 2014-04-09 | Last modified: | 2014-04-09 |
|